Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1986 2
1987 1
1988 1
1989 1
1992 1
1994 1
1995 1
1996 3
2000 1
2002 1
2003 1
2006 1
2010 1
2011 1
2012 2
2013 1
2014 2
2015 1
2016 1
2018 2
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents.
Bajor M, Zych AO, Graczyk-Jarzynka A, Muchowicz A, Firczuk M, Trzeciak L, Gaj P, Domagala A, Siernicka M, Zagozdzon A, Siedlecki P, Kniotek M, O'Leary PC, Golab J, Zagozdzon R. Bajor M, et al. Among authors: O'Leary PC. Br J Cancer. 2018 Oct;119(7):873-884. doi: 10.1038/s41416-018-0263-y. Epub 2018 Oct 5. Br J Cancer. 2018. PMID: 30287919 Free PMC article.
Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.
Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, Rawal R, Roef GL, Plantinga TS, Vermeulen SH, Lahti J, Simmonds MJ, Husemoen LL, Freathy RM, Shields BM, Pietzner D, Nagy R, Broer L, Chaker L, Korevaar TI, Plia MG, Sala C, Völker U, Richards JB, Sweep FC, Gieger C, Corre T, Kajantie E, Thuesen B, Taes YE, Visser WE, Hattersley AT, Kratzsch J, Hamilton A, Li W, Homuth G, Lobina M, Mariotti S, Soranzo N, Cocca M, Nauck M, Spielhagen C, Ross A, Arnold A, van de Bunt M, Liyanarachchi S, Heier M, Grabe HJ, Masciullo C, Galesloot TE, Lim EM, Reischl E, Leedman PJ, Lai S, Delitala A, Bremner AP, Philips DI, Beilby JP, Mulas A, Vocale M, Abecasis G, Forsen T, James A, Widen E, Hui J, Prokisch H, Rietzschel EE, Palotie A, Feddema P, Fletcher SJ, Schramm K, Rotter JI, Kluttig A, Radke D, Traglia M, Surdulescu GL, He H, Franklyn JA, Tiller D, Vaidya B, de Meyer T, Jørgensen T, Eriksson JG, O'Leary PC, Wichmann E, Hermus AR, Psaty BM, Ittermann T, Hofman A, Bosi E, Schlessinger D, Wallaschofski H, Pirastu N, Aulchenko YS, de la Chapelle A, Netea-Maier RT, Gough SC, Meyer Zu Schwabedissen H, Frayling TM, Kaufman JM, Linneberg A, Räikkönen K, Smit JW, Kiemeney LA, Rivadeneira F, Uitterlinden AG, Walsh JP, Meisinger C, den Heijer M, Visser TJ, Spector TD, Wilson SG, Völzke H, Cappola A, Toniolo D, Sanna S, Naitza S, Peeters RP. Medici M, et al. Among authors: O'Leary PC. PLoS Genet. 2014 Feb 27;10(2):e1004123. doi: 10.1371/journal.pgen.1004123. eCollection 2014 Feb. PLoS Genet. 2014. PMID: 24586183 Free PMC article.
Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?
Schneider C, Feller M, Bauer DC, Collet TH, da Costa BR, Auer R, Peeters RP, Brown SJ, Bremner AP, O'Leary PC, Feddema P, Leedman PJ, Aujesky D, Walsh JP, Rodondi N. Schneider C, et al. Among authors: O'Leary PC. PLoS One. 2018 Apr 30;13(4):e0196631. doi: 10.1371/journal.pone.0196631. eCollection 2018. PLoS One. 2018. PMID: 29709030 Free PMC article.
Awakening Australia to Rare Diseases: symposium report and preliminary outcomes.
Dawkins HJ, Molster CM, Youngs LM, O'Leary PC. Dawkins HJ, et al. Among authors: O'Leary PC. Orphanet J Rare Dis. 2011 Aug 18;6:57. doi: 10.1186/1750-1172-6-57. Orphanet J Rare Dis. 2011. PMID: 21849083 Free PMC article. No abstract available.
Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.
Cenin DR, Naber SK, de Weerdt AC, Jenkins MA, Preen DB, Ee HC, O'Leary PC, Lansdorp-Vogelaar I. Cenin DR, et al. Among authors: O'Leary PC. Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):10-21. doi: 10.1158/1055-9965.EPI-18-1123. Epub 2019 Nov 20. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31748260
The log TSH-free T4 relationship in a community-based cohort is nonlinear and is influenced by age, smoking and thyroid peroxidase antibody status.
Brown SJ, Bremner AP, Hadlow NC, Feddema P, Leedman PJ, O'Leary PC, Walsh JP. Brown SJ, et al. Among authors: O'Leary PC. Clin Endocrinol (Oxf). 2016 Nov;85(5):789-796. doi: 10.1111/cen.13107. Epub 2016 Jun 19. Clin Endocrinol (Oxf). 2016. PMID: 27197788 Free article.
High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
van den Hurk K, Balint B, Toomey S, O'Leary PC, Unwin L, Sheahan K, McDermott EW, Murphy I, van den Oord JJ, Rafferty M, FitzGerald DM, Moran J, Cummins R, MacEneaney O, Kay EW, O'Brien CP, Finn SP, Heffron CC, Murphy M, Yela R, Power DG, Regan PJ, McDermott CM, O'Keeffe A, Orosz Z, Donnellan PP, Crown JP, Hennessy BT, Gallagher WM. van den Hurk K, et al. Among authors: O'Leary PC. Melanoma Res. 2015 Jun;25(3):189-99. doi: 10.1097/CMR.0000000000000149. Melanoma Res. 2015. PMID: 25746038 Clinical Trial.
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.
O'Leary PC, Terrile M, Bajor M, Gaj P, Hennessy BT, Mills GB, Zagozdzon A, O'Connor DP, Brennan DJ, Connor K, Li J, Gonzalez-Angulo AM, Sun HD, Pu JX, Pontén F, Uhlén M, Jirström K, Nowis DA, Crown JP, Zagozdzon R, Gallagher WM. O'Leary PC, et al. Breast Cancer Res. 2014 Jul 10;16(4):R79. doi: 10.1186/bcr3691. Breast Cancer Res. 2014. PMID: 25011585 Free PMC article.
Age-related changes in thyroid function: a longitudinal study of a community-based cohort.
Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP, Lim EM, Wilson SG, O'Leary PC, Walsh JP. Bremner AP, et al. Among authors: O'Leary PC. J Clin Endocrinol Metab. 2012 May;97(5):1554-62. doi: 10.1210/jc.2011-3020. Epub 2012 Feb 16. J Clin Endocrinol Metab. 2012. PMID: 22344200
28 results
Jump to page
Feedback